These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6979991)

  • 1. Plasma prolactin concentrations and psychopathology in chronic schizophrenia.
    Kleinman JE; Weinberger DR; Rogol AD; Bigelow LB; Klein ST; Gillin JC; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jun; 39(6):655-7. PubMed ID: 6979991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin, psychopathology, and ventricular size in chronic schizophrenia.
    Luchins DJ; Robertson AG; Meltzer HY
    Psychiatry Res; 1984 Jun; 12(2):149-53. PubMed ID: 6147869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY; Busch D
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin responses to domperidone in chronic schizophrenia.
    Nerozzi D; Magnani A; Dastoli C; Ferri E; Capesciotti G; Antonozzi I; Frajese G; Meltzer HY
    Psychiatry Res; 1992 May; 42(2):159-69. PubMed ID: 1631251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prolactin concentration and psychopathology of schizophrenia.
    Otani K; Kondo T; Ishida M; Tanaka O; Yasui N; Suzuki A; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1369-74. PubMed ID: 9004343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
    Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
    Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration of prolactin in the plasma of schizophrenic patients with positive and negative symptoms].
    Prasad AD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(9):1400-1. PubMed ID: 3776429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prolactin level and its correlation with psychopathology in drug free/drug naïve schizophrenia a case control study.
    Wasnik V; Khess CRJ; Munda S; Bijali S
    Asian J Psychiatr; 2019 Jan; 39():1-5. PubMed ID: 30453151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
    Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Frajese G; Antonozzi I; Meltzer HY
    Psychiatry Res; 1990 Nov; 34(2):139-47. PubMed ID: 2149613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of untreated psychosis and time to treatment response for delusions and hallucinations.
    Gunduz-Bruce H; McMeniman M; Robinson DG; Woerner MG; Kane JM; Schooler NR; Lieberman JA
    Am J Psychiatry; 2005 Oct; 162(10):1966-9. PubMed ID: 16199847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
    Jones H; Curtis VA; Wright P; Lucey JV
    Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delusions of pregnancy associated with increased prolactin concentrations produced by antipsychotic treatment.
    Ali JA; Desai KD; Ali LJ
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):111-5. PubMed ID: 12890303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperdopaminergia in schizophreniform psychosis: a chronobiological study.
    Rao ML; Gross G; Halaris A; Huber G; Marler M; Strebel B; Bräunig P
    Psychiatry Res; 1993 May; 47(2):187-203. PubMed ID: 8341771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
    Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
    Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative symptoms: relationship to other schizophrenic symptom classes.
    McKenna PJ; Lund CE; Mortimer AM
    Br J Psychiatry Suppl; 1989 Nov; (7):104-7. PubMed ID: 2619978
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal variations in prolactin levels in schizophrenia.
    Brown PJ; Cleghorn JM; Brown GM; Kaplan RD; Mitton J; Szechtman H; Szechtman B
    Psychiatry Res; 1988 Aug; 25(2):157-62. PubMed ID: 3174903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thought control strategies in schizophrenia: a comparison with non-patients.
    Morrison AP; Wells A
    Behav Res Ther; 2000 Dec; 38(12):1205-9. PubMed ID: 11104184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.